Incyte Financial Statements (INCY)

Incytesmart-lab.ru   2023 2023 2023 2024 2025   LTM ?
Report date 31.12.2023 13.02.2024 16.02.2024 10.02.2025 10.02.2026   28.04.2026
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 3 696 3 696 3 696 4 241 5 141   5 361
Operating Income, bln rub 620.5 651.8 620.5 80.1 1 343   1 439
EBITDA, bln rub ? 904.7 919.4 919.4 408.2 1 760   1 870
Net profit, bln rub ? 597.6 597.6 597.6 32.6 1 287   1 432
OCF, bln rub ? 496.5 496.5 496.5 335.3 1 413   1 517
CAPEX, bln rub ? 47.5 47.5 47.5 86.3 58.9   65.9
FCF, bln rub ? 449.0 449.0 449.0 249.1 1 355   1 451
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 2 791 2 729 1 190 3 783 3 360   3 485
Cost of production, bln rub 255.0 315.2 255.0 377.7 438.7   436.6
R&D, bln rub 1 628 1 628 1 628 2 607 1 984   2 096
Interest expenses, bln rub 2.55 2.55 2.55 2.28 2.43   2.34
Assets, bln rub 6 782 6 782 6 782 5 444 6 958   7 339
Net Assets, bln rub ? 5 190 5 190 5 190 3 448 5 167   5 552
Debt, bln rub 38.3 38.3 38.3 43.5 69.4   33.8
Cash, bln rub 3 656 3 656 3 656 2 158 3 581   4 016
Net debt, bln rub -3 618 -3 618 -3 618 -2 115 -3 511   -3 982
Ordinary share price, rub 62.8 62.8 62.8 69.1 98.8   98.6
Number of ordinary shares, mln 225.9 223.6 223.6 207.1 195.2   199.3
Market cap, bln rub 14 186 14 042 14 042 14 305 19 280   19 647
EV, bln rub ? 10 568 10 424 10 424 12 191 15 769   15 665
Book value, bln rub 4 911 4 911 4 911 3 178 4 917   5 309
EPS, rub ? 2.65 2.67 2.67 0.16 6.59   7.18
FCF/share, rub 1.99 2.01 2.01 1.20 6.94   7.28
BV/share, rub 21.7 22.0 22.0 15.3 25.2   26.6
EBITDA margin, % ? 24.5% 24.9% 24.9% 9.62% 34.2%   34.9%
Net margin, % ? 16.2% 16.2% 16.2% 0.77% 25.0%   26.7%
FCF yield, % ? 3.17% 3.20% 3.20% 1.74% 7.03%   7.38%
ROE, % ? 11.5% 11.5% 11.5% 0.95% 24.9%   25.8%
ROA, % ? 8.81% 8.81% 8.81% 0.60% 18.5%   19.5%
P/E ? 23.7 23.5 23.5 438.6 15.0   13.7
P/FCF 31.6 31.3 31.3 57.4 14.2   13.5
P/S ? 3.84 3.80 3.80 3.37 3.75   3.66
P/BV ? 2.89 2.86 2.86 4.50 3.92   3.70
EV/EBITDA ? 11.7 11.3 11.3 29.9 8.96   8.38
Debt/EBITDA -4.00 -3.93 -3.93 -5.18 -1.99   -2.13
R&D/CAPEX, % 3 428% 3 428% 3 428% 3 022% 3 370%   3 180%
CAPEX/Revenue, % 1.28% 1.28% 1.28% 2.03% 1.14%   1.23%
Incyte shareholders